AI-generated summary
The authors report a photosensitizer, CyI-DNBS, that is taken up by cancer cells and is then activated by intracellular glutathione, releasing singlet oxygen under red light and sulfur dioxide gas. They describe this as combining photodynamic and gas therapy and report an anticancer effect in vivo. The abstract does not give sample sizes, and the work appears to be a laboratory and animal study rather than a clinical trial.
- Who or what was studied
- Cancer cells and in vivo tumor models (animal model; specifics not stated in the abstract)
- Limits stated in the abstract
- The abstract provides no sample size or statistics and does not indicate clinical testing in humans.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on advanced.onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photodynamic therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.